Figure 2.
Incremental cost-effectiveness by liver fibrosis score as measured by METAVIR score. Abbreviations: ICER, incremental cost-effectiveness ratio; PRS/SR, pegylated interferon, ribavirin and sofosbuvir for genotypes 1 and 4, and sofosbuvir and ribavirin for genotypes 2 and 3; SS/SR, sofosbuvir and simeprevir for genotypes 1 and 4, and sofosbuvir and ribavirin for genotypes 2 and 3.